Aerie To Present At The Canaccord Genuity Growth Conference

IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (Nasdaq: AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that Vicente Anido, Jr., Ph.D., Chief Executive Officer and Chairman of the Board, will present at the Canaccord Genuity Growth Conference on Wednesday, August 10, 2016 at 12:30 p.m. Eastern Time in Boston, MA. Dr. Anido will provide an Aerie overview and business update.